DVAX - Financial Reports List - Dynavax Technologies Corporation - IntrinsicAlpha

Dynavax Technologies Corporation DVAX

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US

$ 10.44

1.26 %

$ 1.3 B

Market Cap

52.2

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	29.56%	3119.18%	80.78%
Annual Report	FY	10-K	2024-12-31	19.36%	527.44%	88.87%
Quarterly Report	Q3	8-K	2024-09-30	15.99%	23.10%	97.07%
Quarterly Report	Q2	8-K	2024-06-30	22.48%	231.86%	277.97%
Quarterly Report	Q1	8-K	2024-03-31	8.24%	64.16%	7.56%
Quarterly Report	Q4	8-K	2023-12-31	-69.87%	-99.68%	-13.45%
Annual Report	FY	10-K	2023-12-31	-67.86%	-2.18%	-13.06%
Quarterly Report	Q3	8-K	2023-09-30	-58.56%	-77.60%	-91.67%
Quarterly Report	Q2	8-K	2023-06-30	-76.51%	-97.34%	-2.66%
Quarterly Report	Q1	8-K	2023-03-31	-58.83%	-74.35%	-58.30%

1